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Widely applicable background depletion step enables 
transaminase evolution through solid-phase screening
Matteo Planchestainer,a Eimear Hegarty,a Christian Heckman,a Louise J. Gourlayb and Francesca 
Paradisia,c*
Directed evolution of transaminases is a widespread technique in the development of highly sought-after biocatalysts for 
industrial applications. This process, however, is challenged by the limited availability of effective high-throughput protocols 
to evaluate mutant libraries. Here we report a rapid, reliable, and widely applicable background depletion method for solid-
phase screening of transaminase variants, which was successfully applied to a transaminase from Halomonas elongata 
(HEWT), evolved through rounds of random mutagenesis towards a series of diverse prochiral ketones. This approach 
enabled the identification of transaminase variants in viable cells with significantly improved activity towards para-
substituted acetophenones (up to 60-fold), as well as tetrahydrothiophen-3-one and related substrates. Rationalisation of 
the mutants was assisted by determination of the high-resolution wild-type HEWT crystal structure presented herein.
Introduction
Transaminases have attracted considerable attention for the 
production of compounds containing chiral amino groups, which are 
widespread in the pharmaceutical, agrochemical and fine chemical 
industry.1,2 Of particular interest, in terms of synthetic applications, 
are the amine transaminases (ATAs),  (R)- or (S)-selective enzymes 
that are capable of aminating carbonyls (both aldehydes and 
ketones) in the absence of a neighbouring carboxylic group.3 Despite 
the enormous potential of ATAs, the widespread application of these 
biocatalysts in their wild type form is hindered by a number of 
challenges including limited substrate specificities, substrate and 
product inhibition, and unfavourable reaction equilibria.4
Protein engineering by rational design5–7 and directed evolution8,9 
have played a major role in the ability to address these issues. 
Evolutionary strategies, in particular, are ideally suited to the 
optimisation of the physical properties of enzymes for large-scale 
manufacturing processes, as well as enabling fine-tuning of substrate 
and stereochemical preferences.10,11 The evolution of ATAs by 
Codexis and Merck12,13 pioneered subsequent engineering efforts of 
many ATAs, resulting in the production of an array of highly 
specialised ATAs for chiral amine synthesis.8,9,14 
Even though a fully randomised approach to mutagenesis, targeting 
the whole length of the protein, has become less common, directed 
evolution clearly requires high-throughput screening methods to 
evaluate variable size libraries of engineered variants. The 
generation of smaller, smart libraries designed by rational targeted 
approaches such as CASTing,15 or saturation mutagenesis of specific 
residues identified in silico, still yield a sizable number of clones to 
screen (saturation at three positions affords 8000 variants). The 
identification of hits within live cells is advantageous for library 
screening because, if it is efficient, it prevents culturing of large 
number of clones followed by assays with cell extracts, which, in the 
absence of robotics, is very time-consuming.16 Recently, microfluidic  
screening,17,18 in addition to the application of desorption 
electrospray ionisation mass spectrometry19 on whole colonies, have 
emerged as powerful tools for screening large libraries, however, the 
equipment required in both cases is still highly specialised and 
expensive, therefore they are not yet suitable for widespread 
implementation. Solid-phase screening (SPS), on the other hand, is a 
simpler approach that facilitates the screening of a medium-large 
number of mutant variants based on colorimetric changes that are 
easily observed by the naked eye.20 SPS was successfully applied in 
the evolution of monoamine oxidase (MAO-N) enzymes, using two 
libraries that were fully saturated at two positions each (400 
variants).21 SPS methods applicable to TAs mutant libraries, however, 
are currently limited to a few strategies to screen for amino donors. 
Wu and co-workers, for example, reported the use of SPS to screen 
libraries of approximately 100,000 ATA variants for reduced 
inhibition towards methoxyisopropylamine.22 Later, Bornscheuer 
and colleagues applied SPS to evolve an ATA towards suitable amino 
donors (screening ca 4600 colonies), however this required co-
expression of a second enzyme as a coupled reporting system, 
increasing the complexity of the system.23,24 Similarly, Turner and co-
workers evolved SPS for ATAs library screening, specifically to 
identify either (R)- or (S)-selective ATAs (screening ca. 1000 colonies), 
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which also required multiple reporting enzymes, as well as flash-
freezing in liquid nitrogen, to increase permeability.25  
Screening strategies for varying carbonyl acceptors, which are key 
substrates for ATAs to produce chiral amine products, appear to be 
much more challenging. Ortho-xylylenediamine26 and 4-
nitrophenethylamine27 have been recently reported as amine donors 
in proof of concept studies to rapidly generate coloured by-products 
upon transamination. Both these strategies suffer from strong 
background interference in live cells due to endogenous pyruvate 
which is nearly always an excellent substrate for ATAs; in a mutant 
library screening, the number of false positives is certain to be 
significant without an efficient system to deplete background. 
Pyruvate is a primary metabolite, essential for cell growth, therefore 
knock-out strategies are not feasible, making it inherently difficult to 
minimise the background noise in SPS. 
We here report the development of a simple and reliable SPS method 
that encapsulates (S)-1-phenylethylamine as a straightforward 
background depletion agent to minimize high levels of pyruvate 
activity. To highlight the power of this methodology, we successfully 
applied it to the screening of a fully randomised mutant library of an 
(S)-selective ATA from Halomonas elongata (HEWT)28  against a 
series of prochiral aromatic and cyclic ketones. In addition, the 
crystal structure of the wild-type HEWT is reported, which facilitated 
rationalisation of the mutations introduced.
Results and discussion
Depletion of background activity and test screening. 
Reliable methodology to quench background activity, which leads to 
a high number of false positives, was designed to specifically deplete 
endogenous pyruvate. Unlike previously discussed methods, our 
alternative approach is based on pre-reacting cellular pyruvate with 
(S)-1-phenylethylamine. The reaction is catalysed by the expressed 
transaminase to produce alanine and acetophenone with an 
extremely favourable equilibrium, effectively removing pyruvate as 
a non-specific acceptor from the environment. The screening was 
initially optimised with E. coli BL21(DE3) cells expressing wild-type 
HEWT, which were spread onto a nitrocellulose membrane 
deposited on a LB-agar plate. This permitted easy transfer of the 
colonies through the different assay steps (Figure S1). Following 
expression and dialysis (Experimental in the ESI), the membrane was 
left for 30 minutes on filter paper soaked with (S)-1-
phenylethylamine and then washed with 50 mM phosphate buffer, 
pH 8. 
Test screening of pre-treated colonies to establish timelines and 
reaction efficiency, were performed with both pyruvate and 
acetophenone and compared with a control plate not supplemented 
with any amino acceptor (Figure S2). Ortho-xylylenediamine was 
used in the first instance as an amino donor. The control plate did 
not give any colorimetric change up to two hours, after which time a 
slightly brown tinge could be observed likely due to the cell healthy 
metabolic system producing sufficient amounts of pyruvate 
detectable through the reaction. In the absence of the background 
depletion step, the cells almost immediately respond to the amino 
donor preventing any significant discrimination between exogenous 
amino acceptor and the endogenous pyruvate (Figure 1), as was also 
observed by O’Reilly and co-workers.26 Likewise, the addition of 
pyruvate to the membrane as the amino acceptor, causes visible 
darkening of the colonies within 5 minutes of incubation. 
Acetophenone, which in liquid-phase assays had shown no 
detectable activity with wild-type HEWT, performs similarly to the 
control plate, with no observable colour formation during total 
incubation (Figure S2). The mild treatment, preserved cell viability, 
which is essential for the direct growth and plasmid extraction, 
bypassing the need for a replica plate. To further evaluate the 
effectiveness of this strategy, 4-nitrophenethylamine was used as 
amino donor in the assay.27 Remarkably, a significant reduction in 
background noise was observed once more, highlighting the 
transferability of this methodology (should o-xylylenediamine not be 
accepted by the investigated TA). Indeed, the background was even 
further suppressed when compared to the ortho-xylylenediamine 
screen, with barely detectable darkening of the colonies after 24h 
(Figure S3). Liquid nitrogen- and chloroform-induced 
permeabilization steps were attempted also,24,25 but in our case 
neither method was successful. 
Figure 1 - ortho-xylylenediamine solid screening control. E. coli BL21(DE3) cells 
expressing wild-type HEWT after 1 h of incubation with ortho-xylylenediamine at RT, 
following background depletion step (A), and in the absence of such pre-treatment (B).
The use of amines other than (S)-1-phenylethylamine, such as 
isopropylamine and cadaverine, for the background depletion step 
was also investigated. Cadaverine, previously described as a “smart” 
amine donor,29 can be used in ATA reactions ex vivo and may 
effectively convert endogenous pyruvate in whole cells. 
Isopropylamine is a very inexpensive amine donor, commonly used 
in industrial processes;12 the generated acetone is produced in 
minimal quantities and expected to be harmless to colonies. While 
both amines also resulted in a significant reduction in background 
(Figure S4), (S)-1-phenylethylamine appeared to be most effective, 
possibly due to better diffusion of this substrate. However, this 
demonstrates that other amines can also be used to quench 
endogenous pyruvate, for example with aminotransferases that do 
not accept 1-phenylethylamine as a substrate.
Evolution towards substituted acetophenones. 
To test the methodology, HEWT was subjected to directed evolution 
using error-prone PCR to generate a completely randomised mutant 
library with a high number of mutations. The enzyme has minimal 
activity towards the aromatic substrate para-nitroacetophenone 
(1a) and this was selected as the amino acceptor for the initial 
screening, using ortho-xylylenediamine as the amino donor. DMSO 
(10 % (v/v)) was required for substrate solubility and enhanced cell-
permeability. The discrimination between wild-type and an 
improved variant relies on the rapidity with which the enzyme 
converts the substrate in vivo. Screening of ca. 15000 colonies 
provided two variants with enhanced catalytic activity towards para-
nitroacetophenone. The two new variants (referred to as A1 and B1) 
were expressed and purified for further characterisation. They 
exhibited a 2-fold increase in turnover frequency with respect to the 
wild-type, achieved higher conversion after 2 hours, and maintained 
excellent enantioselectivity (Table 1). Both variants were subjected 
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to a second round of error-prone PCR and the libraries screened as 
before with 1a. Interestingly, in this case the positive colonies were 
isolated after a significantly shorter incubation period (2-15 minutes 
compared to 25 minutes for the parental colony). While the A1 
Table 1 - HEWT evolution towards substituted acetophenones. Turnover frequencies (TOF) measured at 10 mM carbonyl concentration, 2-hour molar conversions (m.c.), and 
enantiomeric excess (e.e.) for wild-type HEWT and isolated variants towards para-nitro- (1a) and para-cyanoacetophenone (2a).
PyruvateL-Alanine
HEWT
O
Ar Ar
NH2
1–2a 1–2b
WT A1 B1 B2 B3
Substrate
TOF 
(10-3 s-1)
m.c.
(%)
e.e.
(%)
TOF
(10-3 s-1)
m.c.
(%)
e.e.
(%)
TOF
(10-3 s-1)
m.c.
(%)
e.e.
(%)
TOF
(10-3 s-1)
m.c.
(%)
e.e.
(%)
TOF
(10-3 s-1)
m.c.
(%)
e.e.
(%)
O
O2N 1a
36 ± 6 4 > 99 (S) 66 ± 9 6 > 99 (S) 65 ± 26 6 > 99 (S) 92 ± 5 7 > 99 (S) 84 ± 14 7 >99(S)
O
NC 2a
4 ± 1 9 87 (S) 50 ± 7 11 94 (S) 127 ± 5 12 > 99 (S)
229 ± 7 11
 
> 99 
(S) 246 ± 7 12
>99
(S)
Biotransformation reactions were performed with 10 mM ketones, 500 mM L-Alanine, 0.1 mM PLP, 0.1 mg/mL (1.9 µM) enzyme in 50 mM phosphate buffer pH 8 and 10% 
(v/v) DMSO at 37 °C (See Experimental in the ESI, Figure S9). All experiments were conducted in triplicate and the standard error is reported accordingly. Mutations;  A1: W56C, 
V435A; B1: W56C, L211V, L306M; B2: W56C, L211V, L306M, V361A, Q388R, P453L; B3: W56C, L211V, A254V, L306M, V361A, Q388R, P453L.
template did not provide any significant hits, an improved variant 
was isolated from the B1 library. The new mutant, identified as B2, 
afforded comparable molar conversion after 2 hours and a further 
1.5-fold increase in turn-over frequency (Table 1). The e.e. measured 
at 24h was in all cases >99% (though the overall yields were low due 
to experimental conditions needed to assess the kinetic behaviour of 
the mutants). A third round of mutagenesis, using the B2 variant as 
a template, initially failed to identify better variants, as the colour 
change on solid screening was too rapid and did not allow 
discrimination between parental activity and mutants. Reducing the 
concentration of para-nitroacetophenone and ortho-
xylylenediamine from 10 mM to 1 mM, with just 5 % (v/v) DMSO 
prolonged the screening window to ca. 1 h. An additional variant, B3, 
was isolated from the screening and while, upon purification, it 
displayed comparable reaction velocity and 2h conversions to B2, it 
had 2-fold higher expression levels which is justifies a more rapid 
colour development with respect to the parental variant. Each 
variant was also fully characterised in term of activity and stability at 
different temperatures and pHs. In all the cases, the mutants 
generated did not show significant alterations when compared to the 
WT enzyme (Figure S5-8). 
A second substrate, para-cyanoacetophenone (2a), was also 
investigated. HEWT wild-type has negligible activity towards this 
molecule, even lower than the nitro substitution, with a turnover 
frequency of 4 10-3 s-1. The B2 variant showed an impressive 60-fold 
increase in turn-over frequency (229 10-3 s-1), and enhanced 
stereoselectivity, affording >99% of the (S)-enantiomer (Table 1). 
Again, B3 showed virtually identical catalytic properties to B2.
Evolution towards small cyclic ketones. 
To further expand the catalytic scope of HEWT, the original mutant 
library was screened towards a structurally different substrate, 
tetrahydrothiophen-3-one (3a), a small cyclic ketone which if 
successfully aminated yields a chiral amine (3b) that has potential 
use as a building block for active pharmaceutical ingredients.30
In this case, the wild-type enzyme already possesses some activity 
towards the target substrate (3a), with a turnover frequency of 206 
10-3 s-1 and complete molar conversion (>99%) after 24 h using 
equimolar amounts of (S)-1-phenylethylamine as donor and higher 
catalyst concentration (1 mg/mL - 19 µM). The optimised solid phase 
screening with ortho-xylylenediamine yielded a new variant (C1) 
which, upon expression and purification, displayed a 2-fold increase 
in turnover frequency (Table 2). On this occasion, the mutant showed 
a colour change after 18 minutes, compared to 30 minutes for the 
wild-type control. Notably, the variant matched the excellent 
conversion displayed by the wild-type enzyme, affording the (S)-
enantiomer of the corresponding amine with >99% conversion and 
66% e.e. 
The C1 variant was subsequently screened against a panel of 
representative cyclic ketones (Table 2, 4a, 5a, 6a). The mutant had 
improved TOF with both tetrahydrofuan-3-one (4a) and 1-methyl-
piperidin-3-one (6a) (35% and 90% increase, respectively) but it was 
in fact slower with 1-methypyrrolidin-3-one (5a) (see Table S1). 
Similarly to what was observed with the library evolved towards 
para-nitroacetophenone, an additional round of mutagenesis did not 
permit the identification of better variants towards 
tetrahydrothiophen-3-one (3a) as the colour change on the plates 
was too rapid to discriminate further enhanced variants. 
This clearly demonstrates that this solid phase screen is able to 
identify better variants, both in terms of TOFs and expression levels, 
from libraries that are of desirable size for semi-rational approaches 
to directed evolution.10 The application of this methodology was 
successful even with a fully randomised approach which can only 
afford limited improvement of the mutants do to the high probability 
of unsuitable mutations.31 
3D structural analysis of wild type HEWT and mutant variants. 
In order to understand the effect of the various mutations on wild-
type HEWT, the crystal structure was determined at a resolution of 2 
Å, as described in the methods. Atomic coordinates and structure 
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factors have been deposited in the Protein Data Bank (www.rcsb.org) 
under PDB accession code 6GWI.
Two identical HEWT monomers (Chains A and B; RMSD 0.23 Å) were 
present in the asymmetric unit (Matthews coefficient = 2.14 Å3 Da-1), 
with an estimated solvent content of 42.5% (see Table S2). This 
homodimer arrangement is biologically relevant as HEWT is a
Table 2 - HEWT evolution toward small cyclic ketones. Turnover frequencies (TOF) measured at 10 mM carbonyl concentration, molar conversions (m.c.), and enantiomeric excess 
(e.e.) for wild-type HEWT and isolated variants towards tetrahydrothiophen-3-one (3a) tetrahydrofuran-3-one (4a), 1-methylpyrrolidin-3-one (5a) and 1-methyl-piperidin-3-one (6a). 
Final conversion was obtained within 2 hours of reaction.
(S)-1-phenylethylamine
HEWT
Acetophenone
X
O
X
NH2
3–6a 3–6b
WT C1
Substrate TOF(10-3 s-1)
m.c.
(%)
e.e.
(%)
TOF
(10-3 s-1)
m.c.
(%)
e.e.
(%)
O
3a
S
206 ± 5 >99 66 (S) 460 ± 6 >99 66 (S)
O
4a
O
430 ± 1 >99 70 (S) 580 ± 3 >99 70 (S)
O
5a
NMe
18 ± 0.2 94 90 (S) 11.6 ± 0.3 94 90 (S)
6a
NMe
O
10 ± 0.8 98 90 (S) 19 ± 0.8 98 90 (S)
Biotransformation reactions were performed with 10 mM ketones, 10 mM (S)-1-phenylethylamine, 0.1 mM PLP, 1 mg/mL (19 µM) enzyme in 50 mM 
phosphate buffer pH 8 and 10% (v/v) DMSO at 37 °C (See Experimental in the ESI, Figure S10). All experiments were conducted in triplicate and the standard 
error is reported accordingly. Mutation in C1: D5E.
catalytically active dimer. Electron density was present for residues 
2 to 451 (Chain A) and 1 to 450 (Chain B). The HEWT monomer 
comprises 3 sub-domains: i) a principle PLP-dependent transferase-
like domain (residues 82 to 318) that hosts a central mixed -sheet, 
comprising 7 strands, (9-8-10-11-12-13-7), with -strand 13 
being antiparallel to the rest, surrounded by 9 -helices and two 310 
helices (1-2) (Figure 2); ii) domain 2 (residues 2-79; 320-451) that 
contains a small N-terminal sub-domain (residues 2 to 32; 1-1-2-
2-3-5) which forms the main interactions with the opposing 
monomer. One molecule of pyridoxal-5'-phosphate (PLP), produced 
by the covalent attachment to the -amino group of the catalytic 
lysine (K284), via an aldimine linkage, is bound to each monomer. 
Dimerisation involves 100 residues contributed from each monomer, 
with an interface area of 5395 Å2. The main dimerisation interactions 
include 4 salt bridges and 47 hydrogen bonds, as calculated by 
PDBsum available from the European Bioinformatics Institute 
(www.ebi.ac.uk). 
Based on a secondary structure-based homology search, the DALI 
server identified the 4-aminobutyrate transaminase from 
Pseudomonas as the top hit (PDB entry 5KR6; unpublished) with a 
RMSD of 1.3Å over 445/460 aligned main chain residues.32 Sequence 
and structure conservation between HEWT and all other structures 
deposited in the PDB was assessed using ENDscript 2.0 
(http://endscript.ibcp.fr).33 HEWT was compared with 124 structures 
with sequence conservation >30%. As expected, the highest 
conservation (sequence and structural) is located in the PLP- 
dependent transferase-like domain and active site region (Figure 3A).
Sequencing of the selected mutants identified two amino acid 
changes in the A1 variant, (W56C, V435A), while the B1 variant 
displayed three amino acid substitutions (W56C, L211V, L306M) 
(Notes in the ESI). Interestingly, both mutants harbour a tryptophan 
to cysteine change in position 56, which is located in the active site. 
This residue has previously been identified as a hotspot in in silico 
rational design studies.7,34 In this case, removing the large indole ring 
and replacing it with the smaller cysteine side chain allows for easier 
substrate binding. Furthermore, the thiol can promote hydrogen 
bonding with the aromatic substituent and stabilise para-
nitroacetophenone (Figure 3B, 3C). Accordingly, W56 is located in a 
highly structurally conserved region (Figure 3A), as is V435 (Figure 
3A). The L306M mutation is peripheral and not conserved with 
regards to sequence, and therefore less conserved than the A1 
mutations with regards to structure, and therefore is somewhat 
more difficult to rationalise. The L306M mutation introduces a longer 
side chain that may form more stabilising hydrophobic interactions 
with surrounding hydrophobic residues (M126, V302 and F313). 
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From the structure, this hydrophobic cluster may in-turn stabilise 
regions of the protein that mediate dimerisation (Figure S11).  In 
agreement with this hypothesis, thermal stability analysis of the wild-
type and mutant B2 indicates that the latter is more stable (Figure 
S12). The second round of evolution introduced three additional 
mutations (V361A, Q388R, P453L) in the B2 variant, which are also 
located outside of the active site and all are exposed to the solvent; 
their side-chains do not make any significant stabilising 
intramolecular interactions. B3 introduced mostly silent mutations, 
apart from a single A254V mutation neighbouring the D255 residue, 
forming a hydrogen bond with the pyridine-type nitrogen of the co-
factor PLP.
Figure 2 - The crystal structure of the HEWT WT monomer. Cartoon secondary structure 
representation of the (A) PLP-dependent transferase-like domain (residues 82 to 318), 
with PLP indicated in sticks. For simplicity, the other domain is not coloured. The N-and 
C-termini are labelled. (B) the second domain of HEWT, comprising a subdomain 
(labelled) that mediates dimerisation with the opposing monomer. In this case, the PLP-
dependent domain is not shown for clarity. This figure was generated using Chimera.35
On the other hand, structural analysis of the C1 variant revealed 
a single mutation (D5E) positioned at the N-terminus of the 
protein (Figure 3A). Using the protein structure quasi-rigid 
domain decomposition (PiSQRD) web server 
(http://pisqrd.escience-lab.org),36 the HEWT crystal structure 
(chain A) was decomposed into four sub-domains that can 
behave as independent units during conformational 
fluctuations (Figure S13). D5 is located in domain 4 (residues 2-
34 and 41-46) that adopts an 1-helix-loop-2-helix structure. 
Based on these observations, an aspartate to glutamate 
mutation may alter the local protein dynamics that in-turn may 
cause alterations in the topology of the active site and hence 
substrate specificity and activity. 
Figure 3 - HEWT 3D structure conservation and mutant residue positions. Secondary 
structure of the HEWT monomer shown in sausage representation, as automatically 
generated by ENDscript 2.0 (http://endscript.ibcp.fr).33 Structure conservation between 
chain A of HEWT and 124 structure homologs present in the PDB is indicated by ribbon 
thickness, with regions of low conservation being thicker than highly conserved regions 
(thin regions). Sequence conservation is indicated by red shading; the redder the residue, 
the more conserved it is. Mutated residues in variants A1 (blue), B1 (yellow), B2 (green) 
and C1 (orange) are shown as sticks. The B3 mutant shares all B2 mutations and contains 
an extra A254V mutation (pink sticks). P453 from variants B2 and B3 is not present in the 
model. The N- and C-termini are indicated and PLP is shown in sticks. This figure was 
generated using Pymol 2.0.6. Modelling of the active site for the A1 and B1 mutants, 
where the bulky Trp (the steric encumbrance of the residue is shown as an orange cloud) 
(D) is substituted with a cysteine (E), allowing the aromatic ring substituent (para-
nitroacetophenone in the aldimine intermediate complex with the pyridoxamine 
phosphate (PMP)) to be more easily accommodated.
Conclusions
The introduction of an amine donor as a background depletion agent, 
which exploits the expressed ATA to quench endogenous pyruvate 
proved to be very effective in delivering an efficient screening 
platform for aminotransferase directed evolution. This high-
throughput screening strategy was developed on the basis of the 
ortho-xylylenediamine assay described by O’Reilly and co-workers, 
which was a fundamental tool in the evolution of HEWT towards a 
diverse set of aromatic and cyclic ketones. After three rounds of 
directed evolution, a 2.5-fold increase in activity was obtained for 
para-nitroacetophenone, while with para-cyanoacetophenone the 
identified mutant exhibited a 60-fold higher turnover frequency 
coupled with a substantial improvement of the enantioselectivity 
with respect to the wild type. Furthermore, the evolution towards 
tetrahydrothiophen-3-one yielded a 2-fold increase in the overall 
catalytic efficiency. This enzyme also showed improved catalytic 
properties when screened against similarly challenging cyclic 
ketones. The background depletion step is straightforward and 
reliable, and can be applied to other screening methods where 
endogenous pyruvate interferes with detection making the evolution 
of these enzymes a much less challenging task. The use of 4-
nitrophenethylamine as an alternative reporter, as well as 
alternative amine donors for the depletion step, proved successful. 
The limit of this screen is set by the power of discrimination between 
the mutant and the parent enzyme; if the substrate conversion is too 
fast, the colonies turn black rapidly, which leads to false positives. 
Tuning the screening conditions to slow the reaction can extend the 
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screening window. In addition, through modulation of the parental 
activity, by regulating the expression levels (with the use of a 
promoter that allows for stricter control),37 this screening method 
could be a very powerful tool in further rounds of evolution towards 
the identification of more and more active mutants.
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